DK148344C - Fremgangsmaade til fremstilling af et farmaceutisk praeparat med forlaenget afgivelse af aktivt stof - Google Patents
Fremgangsmaade til fremstilling af et farmaceutisk praeparat med forlaenget afgivelse af aktivt stofInfo
- Publication number
- DK148344C DK148344C DK113676A DK113676A DK148344C DK 148344 C DK148344 C DK 148344C DK 113676 A DK113676 A DK 113676A DK 113676 A DK113676 A DK 113676A DK 148344 C DK148344 C DK 148344C
- Authority
- DK
- Denmark
- Prior art keywords
- preparation
- procedure
- active substance
- extended release
- pharmaceutical preparation
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
Landscapes
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US55910775A | 1975-03-17 | 1975-03-17 | |
| US55910775 | 1975-03-17 | ||
| US65800376A | 1976-02-13 | 1976-02-13 | |
| US65800376 | 1976-02-13 | ||
| KR760000645 | 1976-03-16 | ||
| KR7600645A KR800001387B1 (en) | 1975-03-17 | 1976-03-16 | Process for preparing sustained release formulation |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| DK113676A DK113676A (da) | 1976-09-18 |
| DK148344B DK148344B (da) | 1985-06-17 |
| DK148344C true DK148344C (da) | 1985-11-04 |
Family
ID=27348140
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK113676A DK148344C (da) | 1975-03-17 | 1976-03-16 | Fremgangsmaade til fremstilling af et farmaceutisk praeparat med forlaenget afgivelse af aktivt stof |
Country Status (21)
| Country | Link |
|---|---|
| JP (1) | JPS51115910A (en, 2012) |
| AR (1) | AR222624A1 (en, 2012) |
| AT (1) | AT353415B (en, 2012) |
| AU (1) | AU505355B2 (en, 2012) |
| CA (1) | CA1073358A (en, 2012) |
| CH (1) | CH630257A5 (en, 2012) |
| DD (1) | DD124102A5 (en, 2012) |
| DE (1) | DE2611041A1 (en, 2012) |
| DK (1) | DK148344C (en, 2012) |
| ES (1) | ES446075A1 (en, 2012) |
| FR (1) | FR2304354A1 (en, 2012) |
| GB (1) | GB1546448A (en, 2012) |
| GR (1) | GR60341B (en, 2012) |
| IE (1) | IE43083B1 (en, 2012) |
| LU (1) | LU74558A1 (en, 2012) |
| MC (1) | MC1101A1 (en, 2012) |
| NL (1) | NL190313C (en, 2012) |
| NZ (1) | NZ180321A (en, 2012) |
| PH (1) | PH14927A (en, 2012) |
| PT (1) | PT64907B (en, 2012) |
| SE (1) | SE433804B (en, 2012) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ197543A (en) * | 1980-07-02 | 1984-12-14 | Commw Scient Ind Res Org | Controlled release compositions for inclusion in intraruminal devices |
| CH649215A5 (de) * | 1981-04-29 | 1985-05-15 | Hoffmann La Roche | Pharmazeutische praeparate. |
| CH652025A5 (de) * | 1981-09-14 | 1985-10-31 | Hoffmann La Roche | Pharmazeutisches praeparat. |
| US4421736A (en) * | 1982-05-20 | 1983-12-20 | Merrel Dow Pharmaceuticals Inc. | Sustained release diethylpropion compositions |
| CH666406A5 (de) * | 1984-02-29 | 1988-07-29 | Sandoz Ag | Verfahren zur herstellung von mikrokapseln, welche bromokriptinmesylat als pharmakologischen wirkstoff enthalten. |
| GB2154874B (en) * | 1984-02-29 | 1987-11-04 | Sandoz Ltd | Bromoscriptine compositions |
| AU4064285A (en) * | 1984-03-21 | 1985-10-11 | American Home Products Corporation | Sustained release pharmaceutical capsules |
| JPS6143108A (ja) * | 1984-08-03 | 1986-03-01 | Nippon Shinyaku Co Ltd | 医薬品製剤及びその製造法 |
| NL8600161A (nl) * | 1985-02-05 | 1986-09-01 | Sandoz Ag | Farmaceutische preparaten die 9,10-dihydroergotalkaloiden bevatten. |
| GB8524135D0 (en) * | 1985-10-01 | 1985-11-06 | Sandoz Ltd | Darodipine compositions |
| HU197201B (en) * | 1985-10-01 | 1989-03-28 | Sandoz Ag | Process for producing oral pharmaceutical compositions of controlled solubility of the active components |
| US4786503A (en) * | 1987-04-06 | 1988-11-22 | Alza Corporation | Dosage form comprising parallel lamine |
| US4814178A (en) * | 1987-07-01 | 1989-03-21 | Sanford Bolton | Floating sustained release therapeutic compositions |
| US5133974A (en) * | 1989-05-05 | 1992-07-28 | Kv Pharmaceutical Company | Extended release pharmaceutical formulations |
| IE64128B1 (en) * | 1990-02-26 | 1995-07-12 | Byrne Rynne Holdings Ltd | A pharmaceutical composition |
| CH685978A5 (fr) * | 1991-01-30 | 1995-11-30 | Wellcome Found | Comprimes dispersables dans l'eau. |
| US5629016A (en) * | 1991-01-30 | 1997-05-13 | Glaxo Wellcome Inc. | Water-dispersible tablets |
| WO1992017166A1 (en) * | 1991-04-08 | 1992-10-15 | Nippon Shinyaku Co., Ltd. | Capsule |
| AU668386B2 (en) * | 1992-03-25 | 1996-05-02 | Depomed Systems, Incorporated | Alkyl-substituted cellulose-based sustained-release oral drug dosage forms |
| US5698226A (en) * | 1993-07-13 | 1997-12-16 | Glaxo Wellcome Inc. | Water-dispersible tablets |
| WO1995011667A1 (en) * | 1993-10-29 | 1995-05-04 | R.P. Scherer Corporation | Gelatin capsule fill able to foam |
| CA2174777A1 (en) * | 1993-10-29 | 1995-05-04 | Keith Sugden | Gelatin capsule fill able to foam |
| US5888540A (en) * | 1993-10-29 | 1999-03-30 | Sugden; Keith | Pharmaceutical products |
| US5919491A (en) * | 1994-05-13 | 1999-07-06 | Smithkline Beecham Corporation | Method and composition for increasing calcium uptake |
| JPH10509981A (ja) * | 1994-12-01 | 1998-09-29 | サイバス ファーマシューティカル，インコーポレイティド | 高等植物から得られうる粉末状親水コロイドゴムを用いる持効性薬剤送出 |
| FR2820319B3 (fr) * | 2001-02-08 | 2003-12-05 | Ellipse Pharmaceuticals | Procede de fabrication d'un comprime flottant incluant de l'alfuzosine et comprime obtenu |
| FR2820318B1 (fr) * | 2001-02-08 | 2005-12-23 | Ellipse Pharmaceuticals | Procede de fabrication d'un comprime flottant incluant un principe actif et comprime obtenu |
| EP1245227A1 (en) | 2001-03-31 | 2002-10-02 | Jagotec Ag | A pharmaceutical tablet system that floats in the stomach for programmed release of active substance and process of producing buoyant material contained in same |
| FR2874325B1 (fr) * | 2004-08-19 | 2006-10-20 | Sanofi Synthelabo | Composition pharmaceutique sous forme de comprime a residence gastrique contenant de l'alfuzosine |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1059624B (de) * | 1954-11-11 | 1959-06-18 | Dr Knut Jacobus Sundman | Verfahren zur Herstellung von in einer Traegersubstanz dispergierten Arzneien in dosierter Form |
| JPS5512411B2 (en, 2012) * | 1974-03-12 | 1980-04-02 | ||
| DE2439538C3 (de) * | 1974-08-17 | 1980-07-17 | Ludwig Heumann & Co Gmbh, 8500 Nuernberg | Verfahren zur Herstellung von oral zu verabreichenden Arzneimitteln mit verzögerter Wirkungsfreigabe |
-
1976
- 1976-03-05 CH CH277676A patent/CH630257A5/de not_active IP Right Cessation
- 1976-03-11 IE IE508/76A patent/IE43083B1/en unknown
- 1976-03-15 NZ NZ180321A patent/NZ180321A/xx unknown
- 1976-03-15 LU LU74558A patent/LU74558A1/xx unknown
- 1976-03-15 MC MC761182A patent/MC1101A1/xx unknown
- 1976-03-15 GR GR50306A patent/GR60341B/el unknown
- 1976-03-15 FR FR7607363A patent/FR2304354A1/fr active Granted
- 1976-03-16 CA CA248,018A patent/CA1073358A/en not_active Expired
- 1976-03-16 AT AT192276A patent/AT353415B/de not_active IP Right Cessation
- 1976-03-16 DE DE19762611041 patent/DE2611041A1/de active Granted
- 1976-03-16 ES ES446075A patent/ES446075A1/es not_active Expired
- 1976-03-16 AU AU12049/76A patent/AU505355B2/en not_active Expired
- 1976-03-16 SE SE7603325A patent/SE433804B/xx not_active IP Right Cessation
- 1976-03-16 JP JP51027758A patent/JPS51115910A/ja active Granted
- 1976-03-16 GB GB10482/76A patent/GB1546448A/en not_active Expired
- 1976-03-16 PT PT64907A patent/PT64907B/pt unknown
- 1976-03-16 DD DD191877A patent/DD124102A5/xx unknown
- 1976-03-16 DK DK113676A patent/DK148344C/da not_active IP Right Cessation
- 1976-03-17 AR AR262597A patent/AR222624A1/es active
- 1976-03-17 NL NLAANVRAGE7602776,A patent/NL190313C/xx not_active IP Right Cessation
- 1976-03-29 PH PH18224A patent/PH14927A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IE43083B1 (en) | 1980-12-17 |
| PT64907B (fr) | 1978-03-24 |
| GR60341B (en) | 1978-05-17 |
| PT64907A (fr) | 1976-04-01 |
| GB1546448A (en) | 1979-05-23 |
| NL7602776A (nl) | 1976-09-21 |
| PH14927A (en) | 1982-01-29 |
| LU74558A1 (en, 2012) | 1977-09-27 |
| CA1073358A (en) | 1980-03-11 |
| DK113676A (da) | 1976-09-18 |
| NL190313B (nl) | 1993-08-16 |
| FR2304354A1 (fr) | 1976-10-15 |
| NL190313C (nl) | 1994-01-17 |
| SE433804B (sv) | 1984-06-18 |
| DK148344B (da) | 1985-06-17 |
| AU1204976A (en) | 1977-09-22 |
| DE2611041C2 (en, 2012) | 1988-06-09 |
| AU505355B2 (en) | 1979-11-15 |
| DD124102A5 (en, 2012) | 1977-02-02 |
| AT353415B (de) | 1979-11-12 |
| ES446075A1 (es) | 1977-09-16 |
| MC1101A1 (fr) | 1977-02-04 |
| CH630257A5 (en) | 1982-06-15 |
| NZ180321A (en) | 1978-06-20 |
| AR222624A1 (es) | 1981-06-15 |
| IE43083L (en) | 1976-09-17 |
| ATA192276A (de) | 1979-04-15 |
| DE2611041A1 (de) | 1976-10-14 |
| JPS51115910A (en) | 1976-10-13 |
| SE7603325L (sv) | 1976-09-18 |
| JPS638084B2 (en, 2012) | 1988-02-19 |
| FR2304354B1 (en, 2012) | 1979-04-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK148344C (da) | Fremgangsmaade til fremstilling af et farmaceutisk praeparat med forlaenget afgivelse af aktivt stof | |
| DK513476A (da) | Fremgangsmade til fremstilling af preparater med kontrolleret afgivelse af en virksom bestanddel | |
| DK153773C (da) | Fremgangsmaade til fremstillling af et farmaceutisk praeparat til forlaenget frigoerelse af et laegemiddel | |
| DK371277A (da) | Fremgangsmaade til fremstilling af farmaceutiske doseringsformer med vedvarende virkning | |
| DK567376A (da) | Fremgangsmade til fremstilling af quinazolonderivater | |
| DK48276A (da) | Fremgangsmade til fremstilling af isoxazolylbenzamidderivater | |
| DK562276A (da) | Fremgangsmaade til fremstilling af en farmaceutisk administrationsform | |
| DK431979A (da) | Fremgangsmaade til fremstilling af et stof med bakteriosttisk virkning | |
| DK298476A (da) | Fremgangsmade til fremstilling af 5-benzyl-2-oxazolidonderivater | |
| DK528976A (da) | Fremgangsmade til fremstilling af indazolderivater | |
| DK324176A (da) | Fremgangsmade til fremstilling af orthoaminobutyrophenonderivater | |
| DK523277A (da) | Fremgangsmaade til fremstilling af et farmaceutisk praeparat med protraheret virkning | |
| DK352578A (da) | Fremgangsmaade til fremstilling af et farmaceutisk praeparat | |
| DK143173C (da) | Fremgangsmaade til fremstilling af et urinstof-urinstofphosphatholdigt droevtyggerfoder | |
| DK55376A (da) | Fremgangsmade til fremstilling af beta-dihalogenethenylcyclopropanderivater | |
| DK137275C (da) | Fremgangsmaade til fremstilling af 4-oxo-hexahydropyrazinoisoquinolinderivater | |
| DK497476A (da) | Fremgangsmade til fremstilling af et antibiotisk stof | |
| DK565676A (da) | Fremgangsmade til fremstilling af klavamderivater | |
| DK142990C (da) | Fremgangsmaade til fremstilling af antibakterielt virksomme aldehydderivater af clavulansyre | |
| DK529278A (da) | Fremgangsmaade til fremstilling af farmaceutisk virksomme thiolestere | |
| DK145470C (da) | Fremgangsmaade til fremstilling af et moenstret,biaksialt orienteret,ikke-vaevet stof | |
| DK251176A (da) | Fremgangsmade til fremstilling af cyklopropanolderivater | |
| DK551076A (da) | Fremgangsmade til fremstilling af trifluormethylthio-derivater af cyproheptadin | |
| DK343976A (da) | Fremgangsmade til fremstilling af 5-androsten-17-on-derivater | |
| DK242078A (da) | Fremgangsmaade til fremstilling af et antidepressivt virksomt pharmaceutisk praeparat |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PUP | Patent expired |